Simplex Trading’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.2K Hold
4,400
﹤0.01% 7055
2026
Q1
$27.1K Buy
4,400
+2,000
+83% +$16.6K ﹤0.01% 6493
2025
Q4
$25K Sell
2,400
-10,600
-82% -$106K ﹤0.01% 6269
2025
Q3
$116K Buy
13,000
+10,400
+400% +$91.3K ﹤0.01% 5575
2025
Q2
$33K Buy
2,600
+2,100
+420% +$31.6K ﹤0.01% 6321
2025
Q1
$12K Buy
500
+200
+67% +$5.94K ﹤0.01% 6993
2024
Q4
$10K Buy
300
+100
+50% +$4.51K ﹤0.01% 7211
2024
Q3
$9K Buy
+200
New +$10.2K ﹤0.01% 7278
2024
Q1
Sell
-32,000
Closed -$1.29M 9732
2023
Q4
$1.29M Buy
32,000
+31,000
+3,100% +$909K ﹤0.01% 2775
2023
Q3
$27K Buy
+1,000
New +$29.8K ﹤0.01% 6360

Other funds holding RXST

Simplex Trading's RXST Position: Q2 2026 in Review

Simplex Trading sold out of RxSight (RXST) in Q2 2026, closing a stake of 7,673 shares — an estimated $46.3K sold.

Simplex Trading first reported a position in RXST in Q4 2023 and held it in 6 quarters. The position peaked at $1.19M in Q4 2024. 152 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • Simplex Trading reported no remaining RxSight position as of Q2 2026 after selling out during the quarter.
  • Simplex Trading sold 7,673 RxSight shares in Q2 2026, an estimated $46.3K.
  • Simplex Trading first reported a position in RxSight in Q4 2023 and held it in 6 quarters.
  • Simplex Trading's RxSight position peaked at $1.19M in Q4 2024.
  • 152 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.